Filters
Also try searching for:
*OVO
on 27 Nov 2024
BIOFARMA
2218337 · 05 Sep 2022
005
Class 005
Pharmaceutical Products
Aliments pour bébés; matières pour plomber les dents et pour empreintes dentaires.
Aliments pour bébés; matières pour plomber les dents et pour empreinte...
on 25 Jan 2023
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
2087128 · 01 Dec 2020
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of migraines; pharmaceutical preparations for the treatment of pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of stroke; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, cognitive disorders, schizophrenia, depression; pharmaceutical preparations for the treatment of substance abuse disorders, namely alcoholism and drug addiction; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of prostate disorders; pharmaceutical preparations for the treatment of pulmonary disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of gynecological disorders, namely premenstrual syndrome, endometreosis, yeast infections, menstrual irregularities; pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; pharmaceutical preparations namely smoking cessation preparations; pharmaceutical preparations for the treatment of damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations namely acne medication; pharmaceutical preparations namely allergy medication; pharmaceutical preparations namely antacids; pharmaceutical preparations namely anthelmintics; pharmaceutical preparations namely antiarrhythmics; pharmaceutical preparations namely antibiotics; pharmaceutical preparations namely anticoagulants; pharmaceutical preparations namely anticonvulsants; pharmaceutical preparations namely antidepressants; pharmaceutical preparations namely antiemetics; pharmaceutical preparations namely antiflatulants; pharmaceutical preparations namely antihistamines; pharmaceutical preparations namely antihypertensives; pharmaceutical preparations namely anti-infectives; pharmaceutical preparations namely anti-inflammatories; pharmaceutical preparations namely antiparasitics; pharmaceutical preparations namely antibacterials; pharmaceutical preparations namely antifungals; pharmaceutical preparations namely antivirals; pharmaceutical preparations namely burn relief medication; pharmaceutical preparations namely calcium channel blockers; pharmaceutical preparations namely central nervous system depressants; pharmaceutical preparations namely central nervous system stimulants; pharmaceutical preparations namely cough treatment medication; pharmaceutical preparations namely diarrhea medication; pharmaceutical preparations namely gastrointestinal medication; pharmaceutical preparations namely glaucoma agents; pharmaceutical preparations namely hydrocortisone; pharmaceutical preparations namely hypnotic agents; pharmaceutical preparations namely sedatives.
Pharmaceutical preparations for the treatment of cardiovascular diseas...
on 10 Feb 2016
BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1466325 · 19 Jan 2010
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, solid organ transplant rejection, and auto-immune diseases namely rheumatoid arthritis, multiple sclerosis, lupus, psoriatic arthritis, psoriasis, ankolysing spondylitis, Crohn's disease and ulcerative colitis; pharmaceutical preparations for treatment of the respiratory system; antibiotics, anti-fungals, anti-virals and immunosuppressants; anti-inflammatories and anti-infectives; anti-psychotics; central nervous system stimulants, central nervous system depressants.
Pharmaceutical preparations for the treatment and prevention of obesit...
on 10 Feb 2010
BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1203795 · 21 Jan 2004
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, solid organ transplant rejection, and auto-immune diseases namely rheumatoid arthritis, multiple sclerosis, lupus, psoriatic arthritis, psoriasis, ankolysing spondylitis, Crohn's disease and ulcerative colitis; pharmaceutical preparations for treatment of the respiratory system; antibiotics, anti-fungals, anti-virals and immunosuppressants; anti-inflammatories and anti-infectives; anti-psychotics; central nervous system stimulants, central nervous system depressants.
Pharmaceutical preparations for the treatment and prevention of obesit...
on 18 Mar 2009
BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1169511 · 27 Feb 2003
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases namely rheumatoid arthritis, multiple sclerosis, lupus, psoriatic arthritis, psoriasis, ankolysing spondylitis, Crohn's disease and ulcerative colitis; anti-inflammatories, anti-infectives, antibiotics, anti-psychotics, central nervous system stimulants, central nervous system depressants.
Pharmaceutical preparations for the treatment and prevention of cardio...
on 06 Jun 2001
GOVONI SIM BIANCA S.P.A.
870218 · 24 Feb 1998
005
Class 005
Pharmaceutical Products
Industrial plants, namely complete industrial installations for the mass transfer and processing of raw materials for all industries; pneumatic conveyers; industrial plants for storage, transfer and mixing materials.
007
Class 007
Machinery Products
...
Class 011
Environmental Control Instrument Products (lighting,heating,cooling,cooking)
Industrial plants, namely complete industrial installations for the ma...
Country
CA
Status
All
Registered
Pending
Abandoned
Other
Owners
Bristol-myers squibb company (a delaware corporation) (3)
Biofarma (1)
Boehringer ingelheim international gmbh (1)
Govoni sim bianca s.P.A. (1)
Categories
Class 5 (6)
Class 7 (1)
Class 11 (1)
Correspondents
Gowling wlg (canada) llp (3)
Aventum ip law llp (1)
Marks & clerk (1)
Norton rose fulbright canada llp/s.E.N.C.R.L.,s.R.L. (1)
Image Search
Drag and drop or upload to search any image
End of search results
Page 1 of 1